By Neurotech Business Report Staff
November 3, 2026 | Neurotech Reports announced that Allan May, Co-Founder and Chairman of the Board at Life Science Angels, and Walter Greenleaf, PhD, Neuroscientist, Virtual Reality, and Digital Health Expert at Stanford University’s Virtual Human Interaction Lab, will keynote its 25th Anniversary Neurotech Leaders Forum.
The Neurotech Leaders Forum brings investors and entrepreneurs together to discuss potential dealmaking, the state of the market, M&A activity and exits, and short- and long-term growth forecasts for the industry. Stakeholders can have candid conversations about what attracts investment dollars, how to increase the likelihood of commercialization, and the latest perspectives on compliance and regulation.
“These two pioneers round out an already star-studded collection of speakers and panelists at our 25th Anniversary meeting. We’re excited to see what the next 25 years bring to the neurotech industry,” said James Cavuoto, Editor and Publisher of Neurotech Reports.
“Throughout my 30 years as an investor in neurotech, I’ve seen a lot of great, and a few not-so-great, innovations come along. But there are still plenty of new opportunities on the horizon for neurotech startups,” said keynote speaker Allan May.
Agenda topics covered at this year’s event include neuromodulation, AI-driven brain-computer interfaces (BCIs), bioelectronic medicine, and wearable neurotech. Additional topics include market insights and funding forecasts from investors, as well as panels featuring entrepreneurs from companies looking to scale and commercialize neurotechnology solutions.
Join Allan May, Walter Greenleaf, and other neurotech leaders November 9-10 in South San Francisco to discuss investment opportunities, the latest technologies, and new pathways to commercialization.
